Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.
[cholangiocarcinoma]
High
-mobility
group
AT-hook
2
(
HMGA
2
)
regulates
cell
growth
,
differentiation
,
apoptosis
,
and
neoplastic
transformation
.
Previous
studies
have
shown
that
malignant
tumors
expressing
HMGA
2
,
such
as
gastric
,
lung
,
and
colorectal
carcinomas
,
usually
have
a
poor
prognosis
.
HMGA
2
expression
and
its
clinical
significance
in
intrahepatic
cholangiocarcinomas
have
not
been
studied
.
We
identified
55
intrahepatic
cholangiocarcinomas
resected
at
our
institution
from
1994
to
2003
.
Hematoxylin-eosin-stained
slides
were
reviewed
,
and
histopathologic
characteristics
were
recorded
,
including
mitotic
count
,
tumor
grade
,
vascular
and
perineural
invasion
,
lymph
node
metastasis
,
and
margin
status
.
Using
immunohistochemical
stains
,
we
examined
expression
of
HMGA
2
,
p
53
,
p
16
,
Kit
,
α-fetoprotein
,
and
Ki-
67
,
and
we
analyzed
the
correlation
of
survival
with
clinicopathological
characteristics
and
immunohistochemical
findings
.
Positive
staining
for
HMGA
2
,
p
53
,
p
16
,
Kit
,
α-fetoprotein
,
and
Ki-
67
was
seen
in
18
(
33
%
)
,
37
(
69
%
)
,
26
(
47
%
)
,
21
(
38
%
)
,
2
(
4
%
)
,
and
34
(
63
%
)
tumors
,
respectively
.
HMGA
2
expression
correlated
positively
with
p
53
expression
(
P
=
.
02
;
Ï
=
0
.
32
)
and
negatively
with
p
16
expression
(
P
=
.
04
;
Ï
=
-
0
.
28
)
.
Univariate
analysis
showed
that
HMGA
2
expression
and
lymph
node
metastasis
were
associated
with
shorter
patient
survival
and
were
independent
indicators
of
poor
survival
(
P
=
.
02
and
P
=
.
03
,
respectively
)
.
Tumorigenic
effects
of
HMGA
2
in
intrahepatic
cholangiocarcinoma
may
partly
reflect
its
ability
to
negatively
regulate
expression
of
p
16
tumor
suppressors
and
to
be
associated
with
p
53
abnormalities
.
Diseases
Validation
Diseases presenting
"malignant tumors"
symptom
adrenal incidentaloma
cholangiocarcinoma
coats disease
cowden syndrome
cushing syndrome
dedifferentiated liposarcoma
dentinogenesis imperfecta
esophageal carcinoma
focal myositis
junctional epidermolysis bullosa
liposarcoma
pleomorphic liposarcoma
von hippel-lindau disease
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom